Controlled drug release liposome composition
US9700511B2 · kind B2 · utility
2Cited by
0References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 15, 2014 |
| Grant date | Jul 11, 2017 |
| Priority date | — |
| Expiry date | Mar 15, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/907
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a pharmaceutical composition comprising at least one liposome, at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof, at least one monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent. The present invention also relates to methods of inhibiting cancer cell growth, comprising administering the pharmaceutical composition described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.